TP53 and gastric cancer: In particular, it is well-established in the literature that kaempferol mainly triggers anticancer responses through modulation of the MAPK and Akt pathways, the activation of tumor suppressor genes such as PTEN and p53, and the downregulation of E-cadherin and vimentin, which are relevant to EMT in various carcinomas (breast cancer, cervical cancer, endometrial cancer, ovarian cancer, hepatocellular carcinoma, bile duct cancer, gastric cancer, colon cancer, pancreatic cancer, esophageal cancer, lung cancer, leukemia, bladder cancer, and osteosarcoma cells) [91,92,93].